… , and the estimated protective efficacy was 29% by proportional analysis (11). A recent trial
of this attenuated sporozoite vaccine in Kenya failed to demonstrate significant efficacy in 5- …

… protective efficacy (PPE) against clinical episodes of malaria in a … were predictive of high
levels of protection. Our data suggest that … In this analysis, 100% protective efficacy refers to the …

… Malaria Vaccine Symposium. In this meeting report, we highlight the progress on different
malaria vaccine … and genetic findings that may impact malaria vaccine responses and efficacy. …

… 1a) and based on the previous data with PfSPZ Vaccine, we hypothesize that increasing
numbers of PfSPZ per dose will increase protective efficacy to 100% with the 10-day regimen. …

… In today's Lancet, John Aponte and colleagues report that the candidate malaria vaccine
RTS,S… -protective efficacy. In Gambian adults, vaccine efficacy was 71% in the 9 weeks after last …

… evidence of pre-erythrocytic stage efficacy in phase IIa trials [8]… vaccine-induced blood stage
protection for the first time in a challenge study. This study also shows that protective efficacy …

… RTS,S, formulated with the potent liposomal adjuvant system AS01 from GlaxoSmithKline,
is the only vaccine that has demonstrated protective efficacy against clinical malaria in a …

… efficacy against clinical malaria in a phase II trial in Malian children. We assessed the
cross-protective efficacy of the malaria vaccine … AMA1 were the targets of protective allele-specific …

… 168 and 297 episodes of Plasmodium falciparum malaria were documented in the SPf66 …
crude protective efficacy of 38·8%. Incidence rates for first or only P falciparum malarial …

… to fail or confer only limited protection, the delivery of an efficacious wholecell, live-attenuated
malaria vaccine is likely to be a critical tool by which we can hope to eradicate malaria. …